TY - JOUR AU - Caggiano, V. AU - Weiss, R. V. AU - Rickert, T. S. AU - Linde-Zwirble, W. T. PY - 2005 DA - 2005// TI - Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.20983 DO - 10.1002/cncr.20983 ID - Caggiano2005 ER - TY - JOUR AU - Kuderer, N. M. AU - Dale, D. C. AU - Crawford, J. AU - Cosler, L. E. AU - Lyman, G. H. PY - 2006 DA - 2006// TI - Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients JO - Cancer VL - 15 UR - https://doi.org/10.1002/cncr.21847 DO - 10.1002/cncr.21847 ID - Kuderer2006 ER - TY - CHAP AU - Lyman, G. H. AU - Michels, S. L. AU - Reynolds, M. W. AU - Barron, R. AU - Tomic, K. S. AU - Yu, J. PY - 2010 DA - 2010// TI - Risk of mortality in patients with cancer who experience febrile neutropenia BT - Cancer ID - Lyman2010 ER - TY - JOUR AU - Bosly, A. AU - Bron, D. AU - Van Hoof, A. AU - De Bock, R. AU - Berneman, Z. AU - Ferrant, A. AU - Kaufman, L. AU - Dauwe, M. AU - Verhoef, G. PY - 2008 DA - 2008// TI - Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP JO - Ann Hematol VL - 87 UR - https://doi.org/10.1007/s00277-007-0399-y DO - 10.1007/s00277-007-0399-y ID - Bosly2008 ER - TY - JOUR AU - Pettengell, R. AU - Schwenkglenks, M. AU - Leonard, R. AU - Bosly, A. AU - Paridaens, R. AU - Constenla, M. AU - Szucs, T. D. AU - Jackisch, C. PY - 2008 DA - 2008// TI - Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study JO - Support Care Cancer VL - 16 UR - https://doi.org/10.1007/s00520-008-0430-4 DO - 10.1007/s00520-008-0430-4 ID - Pettengell2008 ER - TY - JOUR AU - Fortner, B. V. AU - Stepanski, E. J. AU - Wang, S. C. AU - Kasprowicz, S. AU - Durrence, H. H. PY - 2002 DA - 2002// TI - Sleep and quality of life in breast cancer patients JO - J Pain Symptom Manage VL - 24 UR - https://doi.org/10.1016/S0885-3924(02)00500-6 DO - 10.1016/S0885-3924(02)00500-6 ID - Fortner2002 ER - TY - CHAP AU - Okon, T. AU - Fortner, B. AU - Schwartzberg, I. AU - Tauer, K. T. AU - Durrence, H. AU - Kovacs, A. AU - Wheetly, K. AU - Woods, C. AU - Taylor, D. AU - Houts, A. C. PY - 2002 DA - 2002// TI - Quality of life (QOL) in patients with grade IV chemotherapy-induced neutropenia (CIN) BT - Proc Am Soc Clin Oncol ID - Okon2002 ER - TY - JOUR AU - Kuderer, N. M. AU - Dale, D. C. AU - Crawford, J. AU - Lyman, G. H. PY - 2007 DA - 2007// TI - Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.8823 DO - 10.1200/JCO.2006.08.8823 ID - Kuderer2007 ER - TY - JOUR AU - Lyman, G. H. AU - Morrison, V. A. AU - Dale, D. C. AU - Crawford, J. AU - Delgado, D. J. AU - Fridman, M. PY - 2003 DA - 2003// TI - Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy JO - Leuk Lymphoma VL - 44 UR - https://doi.org/10.1080/1042819031000119262 DO - 10.1080/1042819031000119262 ID - Lyman2003 ER - TY - JOUR AU - Lyman, G. H. AU - Dale, D. C. AU - Friedberg, J. AU - Crawford, J. AU - Fisher, R. I. PY - 2004 DA - 2004// TI - Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.03.213 DO - 10.1200/JCO.2004.03.213 ID - Lyman2004 ER - TY - JOUR AU - Vogel, C. L. AU - Wojtukiewicz, M. Z. AU - Carroll, R. R. AU - Tjulandin, S. A. AU - Barajas-Figueroa, L. J. AU - Wiens, B. L. AU - Neumann, T. A. AU - Schwartzberg, L. S. PY - 2005 DA - 2005// TI - First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.09.102 DO - 10.1200/JCO.2005.09.102 ID - Vogel2005 ER - TY - JOUR AU - Crawford, J. AU - Wolff, D. AU - Culakova, E. AU - Poniewierski, M. S. AU - Selby, C. AU - Dale, D. PY - 2005 DA - 2005// TI - First cycle risk of severe and febrile neutropenia in cancer patients receiving systemic chemotherapy: results from a prospective nationwide study JO - J Support Oncol VL - 3 ID - Crawford2005 ER - TY - JOUR AU - Martín, M. AU - Lluch, A. AU - Seguí, M. A. AU - Ruiz, A. AU - Ramos, M. AU - Adrover, E. AU - Rodríguez-Lescure, A. AU - Grosse, R. AU - Calvo, L. AU - Fernandez-Chacón, C. AU - Roset, M. AU - Antón, A. AU - Isla, D. AU - del Prado, P. M. AU - Iglesias, L. AU - Zaluski, J. AU - Arcusa, A. AU - López-Vega, J. M. AU - Muñoz, M. AU - Mel, J. R. PY - 2006 DA - 2006// TI - Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdl135 DO - 10.1093/annonc/mdl135 ID - Martín2006 ER - TY - JOUR AU - Chang, J. PY - 2000 DA - 2000// TI - Chemotherapy dose reduction and delay in clinical practice: evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer JO - Eur J Cancer VL - 36 UR - https://doi.org/10.1016/S0959-8049(99)00259-2 DO - 10.1016/S0959-8049(99)00259-2 ID - Chang2000 ER - TY - JOUR AU - Smith, T. AU - Khatcheressian, J. AU - Lyman, G. H. PY - 2006 DA - 2006// TI - 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.4451 DO - 10.1200/JCO.2006.06.4451 ID - Smith2006 ER - TY - JOUR AU - Aapro, M. S. AU - Cameron, D. A. AU - Pettengell, R. AU - Bohlius, J. AU - Crawford, J. AU - Ellis, M. AU - Kearney, N. AU - Lyman, G. H. AU - Tjan-Heijnen, V. C. AU - Walewski, J. AU - Weber, D. C. AU - Zielinski, C. PY - 2006 DA - 2006// TI - EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours JO - Eur J Cancer VL - 42 UR - https://doi.org/10.1016/j.ejca.2006.05.002 DO - 10.1016/j.ejca.2006.05.002 ID - Aapro2006 ER - TY - JOUR AU - Greil, R. AU - Psenak, O. AU - Roila, F. PY - 2008 DA - 2008// TI - Hematopoietic growth factors: ESMO recommendations for the applications JO - Ann Oncol VL - 19 ID - Greil2008 ER - TY - JOUR AU - Pettengell, R. AU - Bosly, A. AU - Szucs, T. D. AU - Jackisch, C. AU - Leonard, R. AU - Paridaens, R. AU - Constenla, M. AU - Schwenkglenks, M. PY - 2009 DA - 2009// TI - Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study JO - Br J Haematol VL - 144 UR - https://doi.org/10.1111/j.1365-2141.2008.07514.x DO - 10.1111/j.1365-2141.2008.07514.x ID - Pettengell2009 ER - TY - JOUR AU - Schwenkglenks, M. AU - Jackisch, C. AU - Constenla, M. AU - Kerger, J. N. AU - Paridaens, R. AU - Auerbach, L. AU - Bosly, A. AU - Pettengell, R. AU - Szucs, T. D. AU - Leonard, R. PY - 2006 DA - 2006// TI - Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment JO - Support Care Cancer VL - 14 UR - https://doi.org/10.1007/s00520-006-0034-9 DO - 10.1007/s00520-006-0034-9 ID - Schwenkglenks2006 ER - TY - JOUR PY - 1993 DA - 1993// TI - A predictive model for aggressive non-Hodgkin's lymphoma JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199309303291402 DO - 10.1056/NEJM199309303291402 ID - ref20 ER - TY - JOUR AU - Armitage, J. O. PY - 2005 DA - 2005// TI - Staging non-Hodgkin lymphoma JO - CA-Cancer J Clin VL - 55 UR - https://doi.org/10.3322/canjclin.55.6.368 DO - 10.3322/canjclin.55.6.368 ID - Armitage2005 ER - TY - JOUR AU - Doorduijn, J. K. AU - van der Holt, B. AU - van Imhoff, G. W. AU - van der Hem, K. G. AU - Kramer, M. H. AU - van Oers, M. H. AU - Ossenkoppele, G. J. AU - Schaafsma, M. R. AU - Verdonck, L. F. AU - Verhoef, G. E. AU - Steijaert, M. M. AU - Buijt, I. AU - Uyl-de Groot, C. A. AU - van Agthoven, M. AU - Mulder, A. H. AU - Sonneveld, P. PY - 2003 DA - 2003// TI - CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.01.076 DO - 10.1200/JCO.2003.01.076 ID - Doorduijn2003 ER - TY - JOUR AU - Eldar-Lissai, A. AU - Cosler, L. E. AU - Culakova, E. AU - Lyman, G. H. PY - 2008 DA - 2008// TI - Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy JO - Value Health VL - 11 UR - https://doi.org/10.1111/j.1524-4733.2007.00242.x DO - 10.1111/j.1524-4733.2007.00242.x ID - Eldar-Lissai2008 ER - TY - JOUR AU - Annemans, L. AU - Van Overbeke, N. AU - Standaert, B. AU - Van Belle, S. PY - 2005 DA - 2005// TI - Estimating resource use and cost of prophylactic management of neutropenia with filgrastim JO - J Nurs Manag VL - 13 UR - https://doi.org/10.1111/j.1365-2834.2005.00550.x DO - 10.1111/j.1365-2834.2005.00550.x ID - Annemans2005 ER - TY - JOUR AU - Pascoe, J. AU - Steven, N. PY - 2009 DA - 2009// TI - Antibiotics for the prevention of febrile neutropenia JO - Curr Opin Hematol VL - 16 UR - https://doi.org/10.1097/MOH.0b013e32831ac543 DO - 10.1097/MOH.0b013e32831ac543 ID - Pascoe2009 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/10/642/prepub UR - http://www.biomedcentral.com/1471-2407/10/642/prepub ID - ref26 ER -